- Home
- FGEN vs NTIP Comparison
FGEN vs NTIP Comparison
Compare FGEN & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- NTIP
- Stock Information
- Founded
- FGEN 1993
- NTIP 1990
- Country
- FGEN United States
- NTIP United States
- Employees
- FGEN N/A
- NTIP N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- NTIP Multi-Sector Companies
- Sector
- FGEN Health Care
- NTIP Miscellaneous
- Exchange
- FGEN Nasdaq
- NTIP Nasdaq
- Market Cap
- FGEN 33.5M
- NTIP 28.6M
- IPO Year
- FGEN 2014
- NTIP 1998
- Fundamental
- Price
- FGEN $5.25
- NTIP $1.24
- Analyst Decision
- FGEN Strong Buy
- NTIP
- Analyst Count
- FGEN 1
- NTIP 0
- Target Price
- FGEN $250.00
- NTIP N/A
- AVG Volume (30 Days)
- FGEN 57.0K
- NTIP 13.5K
- Earning Date
- FGEN 08-05-2025
- NTIP 08-11-2025
- Dividend Yield
- FGEN N/A
- NTIP 8.00%
- EPS Growth
- FGEN N/A
- NTIP N/A
- EPS
- FGEN N/A
- NTIP N/A
- Revenue
- FGEN $6,996,000.00
- NTIP $250,000.00
- Revenue This Year
- FGEN N/A
- NTIP N/A
- Revenue Next Year
- FGEN N/A
- NTIP N/A
- P/E Ratio
- FGEN N/A
- NTIP N/A
- Revenue Growth
- FGEN N/A
- NTIP N/A
- 52 Week Low
- FGEN $4.50
- NTIP $1.16
- 52 Week High
- FGEN $38.25
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- FGEN 32.31
- NTIP 50.22
- Support Level
- FGEN $4.85
- NTIP $1.16
- Resistance Level
- FGEN $5.77
- NTIP $1.30
- Average True Range (ATR)
- FGEN 0.57
- NTIP 0.05
- MACD
- FGEN -0.07
- NTIP -0.00
- Stochastic Oscillator
- FGEN 13.22
- NTIP 57.14
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.